SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GRAZI, Gian Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.461
AS - Asia 5.018
EU - Europa 1.581
SA - Sud America 1.331
AF - Africa 154
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.557
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.243
SG - Singapore 2.150
BR - Brasile 1.014
CN - Cina 735
HK - Hong Kong 588
VN - Vietnam 533
IT - Italia 420
BD - Bangladesh 259
FI - Finlandia 227
RU - Federazione Russa 203
ID - Indonesia 179
JP - Giappone 176
FR - Francia 170
DE - Germania 151
GB - Regno Unito 134
IN - India 113
AR - Argentina 102
MX - Messico 98
CA - Canada 70
UA - Ucraina 58
CO - Colombia 56
NL - Olanda 51
TR - Turchia 51
ZA - Sudafrica 51
EC - Ecuador 50
AT - Austria 48
IQ - Iraq 40
CL - Cile 30
PK - Pakistan 28
PY - Paraguay 27
VE - Venezuela 27
SE - Svezia 25
ES - Italia 23
MA - Marocco 23
SA - Arabia Saudita 23
UZ - Uzbekistan 20
KE - Kenya 18
MY - Malesia 16
DZ - Algeria 15
PH - Filippine 14
TN - Tunisia 13
JM - Giamaica 12
AZ - Azerbaigian 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
DO - Repubblica Dominicana 9
JO - Giordania 9
BO - Bolivia 8
CH - Svizzera 8
CR - Costa Rica 8
EG - Egitto 8
LT - Lituania 8
NP - Nepal 8
PL - Polonia 8
IE - Irlanda 7
UY - Uruguay 7
AL - Albania 6
AU - Australia 6
BH - Bahrain 6
IL - Israele 6
TW - Taiwan 6
BY - Bielorussia 5
ET - Etiopia 5
HN - Honduras 5
KR - Corea 5
KZ - Kazakistan 5
SN - Senegal 5
BE - Belgio 4
OM - Oman 4
DK - Danimarca 3
EE - Estonia 3
LB - Libano 3
MO - Macao, regione amministrativa speciale della Cina 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
SV - El Salvador 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AO - Angola 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EU - Europa 2
GR - Grecia 2
HU - Ungheria 2
IR - Iran 2
KW - Kuwait 2
LV - Lettonia 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
SY - Repubblica araba siriana 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BW - Botswana 1
CD - Congo 1
Totale 13.533
Salva come PNG Salva come JPEG
Città #
Singapore 1.120
Ashburn 758
Santa Clara 748
San Jose 730
Hong Kong 585
Fairfield 273
Beijing 250
Council Bluffs 243
Helsinki 219
Ho Chi Minh City 187
Tokyo 171
Chandler 165
Lauterbourg 148
New York 139
Jakarta 133
Hanoi 121
Houston 104
Woodbridge 103
São Paulo 81
Seattle 74
Wilmington 74
Princeton 72
Mexico City 69
Los Angeles 65
Dallas 64
Cambridge 58
Chicago 56
Moscow 56
Orem 48
San Diego 44
Rome 43
Nuremberg 42
Ann Arbor 40
London 39
Shanghai 39
Milan 37
Rio de Janeiro 32
Buffalo 23
Haiphong 23
Salt Lake City 23
Vienna 23
Baghdad 22
Belo Horizonte 21
Jacksonville 21
Chennai 20
Da Nang 20
Quito 20
Curitiba 19
Guangzhou 18
Medellín 18
Porto Alegre 18
Tashkent 18
Frankfurt am Main 17
Montreal 17
Toronto 17
Biên Hòa 16
Bologna 16
Brasília 16
Brooklyn 16
Falkenstein 16
Falls Church 16
Portsmouth 16
Ferrara 14
Nairobi 14
Atlanta 13
Caracas 13
Dhaka 13
Guayaquil 13
Johannesburg 13
Manchester 13
San Francisco 13
Bari 12
Fortaleza 12
Guarulhos 12
Istanbul 12
Mumbai 12
Naples 12
Buenos Aires 11
Amsterdam 10
Asunción 10
Campinas 10
Hangzhou 10
Salvador 10
Santiago 10
Tampa 10
Turin 10
Amman 9
Ankara 9
Baku 9
Charlotte 9
Hải Dương 9
Juiz de Fora 9
New Delhi 9
St Petersburg 9
Can Tho 8
Casablanca 8
Osasco 8
Phoenix 8
Ribeirão Preto 8
Xian 8
Totale 8.102
Salva come PNG Salva come JPEG
Nome #
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 205
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 171
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 169
Tumor Regression Grade After Neoadjuvant Chemoradiation and Surgery for Low Rectal Cancer Evaluated by Multiple Correspondence Analysis: Ten Years as Minimum Follow-up 160
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics 154
The Immune Landscape of Cancer 145
A case report of giant hepatic hemangioma spontaneous regression in adult, non-cirrhotic patient and literature review 140
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis 135
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples 135
Oncogenic Signaling Pathways in The Cancer Genome Atlas 132
Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation. 130
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers 130
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma 115
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily 113
ALPPS for primary and secondary liver tumors 113
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer 111
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 104
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison 103
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics 102
Comprehensive Characterization of Cancer Driver Genes and Mutations 101
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas 99
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines 99
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 99
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 99
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 98
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 98
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer 97
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 97
Pathogenic Germline Variants in 10,389 Adult Cancers 94
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients 93
Genomic and Functional Approaches to Understanding Cancer Aneuploidy 92
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience 92
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 91
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system 90
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation 89
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells 89
Renewed considerations on the utility (or the futility) of hepatic resections for breast cancer liver metastases 88
The Impact of Hospital Volume on Failure to Rescue after Liver Resection for Hepatocellular Carcinoma: Analysis from the HE.RC.O.LE.S. Italian Registry 87
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma 87
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation 86
The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperation 86
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 85
Wnt3a/b-Catenin signaling conditions differentiation of partially exhausted T-effector cells in human cancers 84
Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study 84
Primary leiomyoma of the liver in an immunocompetent patient 83
Genetically driven CD39 expression shapes human tumor-infiltrating CD8+ T-cell functions 83
Laboratory test variability and Model for End-Stage Liver Disease score calculation: effect on liver allocation and proposal for adjustment 82
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma 82
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria 81
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer 81
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas 81
Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selection 81
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period 81
Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 81
Association of polygenic risk score and bacterial toxins at screening colonoscopy with colorectal cancer progression: A multicenter case-control study 81
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome 80
Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53 80
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis 79
Liver resection for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis of risk factors for intrahepatic recurrence 79
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases 79
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population 77
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer 77
Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral units 77
Multiple hepatocellular carcinoma: Long-term outcomes following resection beyond actual guidelines. An Italian multicentric retrospective study 77
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 76
Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years 75
Key components of a hepatobiliary surgery curriculum for general surgery residents: results of the FULCRUM International Delphi consensus 75
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients 75
FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma 75
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 73
Benchmarking postoperative outcomes after open liver surgery for cirrhotic patients with hepatocellular carcinoma in a national cohort 73
Impact of a goal-directed fluid therapy on length of hospital stay and costs of hepatobiliarypancreatic surgery: A prospective observational study 72
Current status of liver surgery for non-colorectal non-neuroendocrine liver metastases: the NON.LI.MET. Italian Society for Endoscopic Surgery and New Technologies (SICE) and Association of Italian Surgeons in Europe (ACIE) collaborative international survey 71
Multicentre evaluation of case volume in minimally invasive hepatectomy 71
Outcome of Right Hepatectomies in Patients Older Than 70 Years 71
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma 70
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 70
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 69
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 69
Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature 69
Efficacy of MELD score in predicting survival after liver retransplantation 68
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era 67
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers 67
Robotic Liver Resections: Application of Difficulty Score Systems to an Initial Experience. Is a Specific Robotic Difficulty Score Necessary? 67
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent 66
A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies 66
Improving the outcome of liver transplantation with very old donors with updated selection and management criteria 66
Liver and partial atrium transplantation for chronic Budd-Chiari syndrome 66
Is it time to develop a robotic difficulty score system? 66
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 66
The peculiar aging of human liver: A geroscience perspective within transplant context 66
The largest western experience on salvage hepatectomy for recurrent hepatocellular carcinoma: propensity score-matched analysis on behalf of He.RC.O.Le.Study Group 66
Recommendations for management of patients with neuroendocrine liver metastases 64
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 64
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 64
Hepatectomy Versus Sorafenib in Advanced Non-Metastatic Hepatocellular Carcinoma: A Real-Life Multicentric Weighted Comparison 64
Laparoscopic Liver Surgery: What Are the Advantages in Patients with Cirrhosis and Portal Hypertension? Systematic Review and Meta-Analysis with Personal Experience 64
Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection 63
Long Term Follow-Up of Patients with De Novo Tumors after 1300 Liver Transplantations: A Case-Control Study 63
Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice? 63
Totale 8.933
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 0 0 25
2021/2022629 15 114 7 6 13 11 127 73 41 22 58 142
2022/2023798 75 45 8 50 46 398 9 41 64 4 35 23
2023/2024498 38 79 38 22 24 18 14 19 19 8 30 189
2024/20253.203 115 49 326 3 378 394 59 129 402 838 238 272
2025/20268.301 467 344 853 1.016 934 318 679 507 1.024 1.285 590 284
Totale 14.075